[Form 4] Insmed, Inc. Insider Trading Activity
Insmed Inc. (INSM) 鈥� Form 4 insider transaction dated 07/15/2025
Chairman & CEO William Lewis, acting through the Katie Procter Dynasty Trust, exercised 6,830 stock options at an exercise price of $10.85 and immediately sold the same 6,830 shares under a Rule 10b5-1 trading plan adopted on 09/12/2024. The shares were disposed of in three tranches at weighted-average prices of $101.71, $102.66 and $103.32, generating roughly $0.7 million in gross proceeds.
Following the transactions, Lewis鈥� total beneficial ownership equals 588,335 common shares (303,911 direct; 233,924 via the Dynasty Trust; 50,500 via the Family Legacy Trust). The option exercise did not change his overall share count, but the sales reduced the Dynasty Trust鈥檚 holdings by 2.8%. No derivative positions were opened or closed other than the exercised option, which now leaves 13,695 options outstanding for the Trust.
The sale size is modest relative to Lewis鈥� remaining stake and was pre-scheduled, limiting signaling value. Nevertheless, investors often view insider disposals, especially near 52-week highs (INSM traded >$100), as a potential sentiment check.
Insmed Inc. (INSM) 鈥� Transazione insider Form 4 datata 15/07/2025
Il Presidente e CEO William Lewis, agendo tramite il Katie Procter Dynasty Trust, ha esercitato 6.830 opzioni su azioni al prezzo di esercizio di 10,85$ e ha immediatamente venduto le stesse 6.830 azioni nell'ambito di un piano di trading Rule 10b5-1 adottato il 12/09/2024. Le azioni sono state cedute in tre tranche a prezzi medi ponderati di 101,71$, 102,66$ e 103,32$, generando circa 0,7 milioni di dollari di proventi lordi.
A seguito delle transazioni, la propriet脿 totale beneficiaria di Lewis ammonta a 588.335 azioni ordinarie (303.911 dirette; 233.924 tramite il Dynasty Trust; 50.500 tramite il Family Legacy Trust). L'esercizio delle opzioni non ha modificato il numero complessivo di azioni detenute, ma le vendite hanno ridotto la quota del Dynasty Trust del 2,8%. Non sono state aperte o chiuse altre posizioni derivative oltre all'opzione esercitata, che lascia ora 13.695 opzioni in essere per il Trust.
La dimensione della vendita 猫 modesta rispetto alla quota residua di Lewis ed 猫 stata programmata in anticipo, limitando il valore di segnale. Tuttavia, gli investitori spesso interpretano le vendite da parte degli insider, specialmente vicino ai massimi delle 52 settimane (INSM ha superato i 100$), come un possibile indicatore di sentiment.
Insmed Inc. (INSM) 鈥� Transacci贸n insider Formulario 4 fechada 15/07/2025
El presidente y CEO William Lewis, actuando a trav茅s del Katie Procter Dynasty Trust, ejerci贸 6.830 opciones sobre acciones a un precio de ejercicio de 10,85$ y vendi贸 inmediatamente las mismas 6.830 acciones bajo un plan de negociaci贸n Rule 10b5-1 adoptado el 12/09/2024. Las acciones se dispusieron en tres tramos a precios promedio ponderados de 101,71$, 102,66$ y 103,32$, generando aproximadamente 0,7 millones de d贸lares en ingresos brutos.
Tras las transacciones, la propiedad beneficiaria total de Lewis es de 588.335 acciones comunes (303.911 directas; 233.924 a trav茅s del Dynasty Trust; 50.500 a trav茅s del Family Legacy Trust). El ejercicio de las opciones no cambi贸 su conteo total de acciones, pero las ventas redujeron la participaci贸n del Dynasty Trust en un 2,8%. No se abrieron ni cerraron otras posiciones derivadas aparte de la opci贸n ejercida, que ahora deja 13.695 opciones pendientes para el Trust.
El tama帽o de la venta es modesto en relaci贸n con la participaci贸n restante de Lewis y fue programado previamente, limitando su valor como se帽al. Sin embargo, los inversores suelen ver las disposiciones de insiders, especialmente cerca de m谩ximos de 52 semanas (INSM cotiz贸 por encima de 100$), como un posible indicador de sentimiento.
Insmed Inc. (INSM) 鈥� 2025雲� 7鞗� 15鞚检瀽 Form 4 雮措秬鞛� 瓯半灅
須岇灔 瓴� CEO William Lewis電� Katie Procter Dynasty Trust毳� 韱淀暣 頄夓偓臧�瓴� $10.85鞐� 6,830欤� 欤检嫕 鞓奠厴鞚� 頄夓偓頃橁碃, 2024雲� 9鞗� 12鞚� 毂勴儩霅� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 霃欖澕頃� 6,830欤茧ゼ 歃夓嫓 毵る弰頄堨姷雼堧嫟. 欤检嫕鞚� 靹� 彀鞐� 瓯胳硱 臧�欷戫弶攴� 臧�瓴� $101.71, $102.66, $103.32鞐� 觳橂秳霅橃柎 鞎� 70毵� 雼煬鞚� 齑� 靾橃澋鞚� 彀届稖頄堨姷雼堧嫟.
鞚措矆 瓯半灅 頉� Lewis鞚� 齑� 鞁れ 靻岇湢 欤检嫕 靾橂姅 588,335欤� 氤错喌欤�搿� (歆侅爲 303,911欤�; Dynasty Trust毳� 韱淀暣 233,924欤�; Family Legacy Trust毳� 韱淀暣 50,500欤�) 甑劚霅╇媹雼�. 鞓奠厴 頄夓偓電� 鞝勳泊 欤检嫕 靾橃棎電� 氤�霃欖潉 欤检 鞎婌晿鞙茧倶, 毵る弰電� Dynasty Trust鞚� 歆�攵勳潉 2.8% 臧愳唽鞁滌及鞀惦媹雼�. 頄夓偓霅� 鞓奠厴 鞕胳棎 雼るジ 韺岇儩靸來拡 韽靺橃潃 臧滌劋霅橁卑雮� 觳偘霅橃 鞎婌晿鞙茧┌, 順勳灛 Trust鞐愲姅 13,695臧滌潣 鞓奠厴鞚� 雮晞 鞛堨姷雼堧嫟.
毵る弰 攴滊電� Lewis鞚� 雮潃 歆�攵勳棎 牍勴暣 鞝侅潃 韼胳澊氅� 靷爠鞐� 瓿勴殟霅� 瓯半灅搿� 鞁犿樃 臧�旃橁皜 鞝滍暅鞝侅瀰雼堧嫟. 攴鸽熂鞐愲弰 攵堦惮頃橁碃 韴瀽鞛愲摛鞚� 雮措秬鞛� 毵る弰毳�, 韸鬼瀳 52欤� 斓滉碃臧� 攴检矘鞐愳劀(INSM鞚� $100 鞚挫儊 瓯半灅霅�) 膦呾 鞁滌灔 鞁Μ 鞝愱瞼 鞁犿樃搿� 臧勳＜頃╇媹雼�.
Insmed Inc. (INSM) 鈥� Transaction d鈥檌niti茅 Formulaire 4 dat茅e du 15/07/2025
Le Pr茅sident et CEO William Lewis, agissant par l鈥檌nterm茅diaire du Katie Procter Dynasty Trust, a exerc茅 6 830 options d鈥檃chat d鈥檃ctions au prix d鈥檈xercice de 10,85$ et a imm茅diatement vendu les m锚mes 6 830 actions dans le cadre d鈥檜n plan de trading Rule 10b5-1 adopt茅 le 12/09/2024. Les actions ont 茅t茅 c茅d茅es en trois tranches 脿 des prix moyens pond茅r茅s de 101,71$, 102,66$ et 103,32$, g茅n茅rant environ 0,7 million de dollars de produit brut.
脌 la suite de ces op茅rations, la d茅tention b茅n茅ficiaire totale de Lewis s鈥櫭﹍猫ve 脿 588 335 actions ordinaires (303 911 en direct ; 233 924 via le Dynasty Trust ; 50 500 via le Family Legacy Trust). L鈥檈xercice des options n鈥檃 pas modifi茅 son nombre total d鈥檃ctions, mais les ventes ont r茅duit la participation du Dynasty Trust de 2,8 %. Aucune autre position d茅riv茅e n鈥檃 茅t茅 ouverte ou cl么tur茅e en dehors de l鈥檕ption exerc茅e, laissant d茅sormais 13 695 options en circulation pour le Trust.
La taille de la vente est modeste par rapport 脿 la participation restante de Lewis et a 茅t茅 programm茅e 脿 l鈥檃vance, limitant ainsi sa valeur en tant que signal. N茅anmoins, les investisseurs consid猫rent souvent les ventes d鈥檌niti茅s, surtout pr猫s des plus hauts sur 52 semaines (INSM a d茅pass茅 les 100$), comme un indicateur potentiel du sentiment du march茅.
Insmed Inc. (INSM) 鈥� Insider-Transaktion Form 4 vom 15.07.2025
Vorsitzender und CEO William Lewis hat 眉ber den Katie Procter Dynasty Trust 6.830 Aktienoptionen zum Aus眉bungspreis von 10,85$ ausge眉bt und unmittelbar dieselben 6.830 Aktien im Rahmen eines Rule 10b5-1 Handelsplans verkauft, der am 12.09.2024 eingef眉hrt wurde. Die Aktien wurden in drei Tranchen zu gewichteten Durchschnittspreisen von 101,71$, 102,66$ und 103,32$ ver盲u脽ert, was Bruttoerl枚se von etwa 0,7 Millionen Dollar einbrachte.
Nach den Transaktionen besitzt Lewis insgesamt 588.335 Stammaktien (303.911 direkt; 233.924 眉ber den Dynasty Trust; 50.500 眉ber den Family Legacy Trust). Die Optionsaus眉bung 盲nderte seine Gesamtanzahl an Aktien nicht, jedoch verringerten die Verk盲ufe den Anteil des Dynasty Trust um 2,8%. Es wurden keine weiteren Derivatepositionen er枚ffnet oder geschlossen, au脽er der ausge眉bten Option, wodurch nun 13.695 Optionen f眉r den Trust verbleiben.
Die Verkaufsgr枚脽e ist im Verh盲ltnis zu Lewis鈥� verbleibendem Anteil gering und war vorab geplant, was den Signalwert begrenzt. Dennoch sehen Investoren Insiderverk盲ufe, insbesondere nahe 52-Wochen-Hochs (INSM notierte 眉ber 100$), oft als m枚glichen Stimmungsindikator.
- Transparent 10b5-1 plan reduces potential for insider-trading concerns.
- CEO retains a substantial 588,335-share stake, preserving alignment with shareholders.
- Sale of 6,830 shares at >$100 may be interpreted as reduced short-term confidence.
- Cashless exercise monetizes gains rather than increasing ownership, a mildly negative signal.
Insights
TL;DR: Pre-planned option exercise & small sale; largely neutral for valuation.
The CEO converted in-the-money options struck at $10.85 (鈮�90% discount to market) and sold the shares at 鈮�$102 to monetize gains while keeping his total equity exposure unchanged. Because the transaction was executed under a 10b5-1 plan and represents < 1.2% of his total holdings, it does not materially alter insider ownership or suggest a strategic shift. I view the filing as neutral; it neither strengthens nor weakens the investment thesis.
TL;DR: Governance-friendly disclosure; minor negative optics from insider selling.
Transparent use of a 10b5-1 plan mitigates concerns over trading on MNPI, aligning with best practices. Still, public perception may skew negative because the disposal occurred near all-time highs, and cashless exercises can signal management鈥檚 view of limited near-term upside. Overall impact is slightly negative but not material.
Insmed Inc. (INSM) 鈥� Transazione insider Form 4 datata 15/07/2025
Il Presidente e CEO William Lewis, agendo tramite il Katie Procter Dynasty Trust, ha esercitato 6.830 opzioni su azioni al prezzo di esercizio di 10,85$ e ha immediatamente venduto le stesse 6.830 azioni nell'ambito di un piano di trading Rule 10b5-1 adottato il 12/09/2024. Le azioni sono state cedute in tre tranche a prezzi medi ponderati di 101,71$, 102,66$ e 103,32$, generando circa 0,7 milioni di dollari di proventi lordi.
A seguito delle transazioni, la propriet脿 totale beneficiaria di Lewis ammonta a 588.335 azioni ordinarie (303.911 dirette; 233.924 tramite il Dynasty Trust; 50.500 tramite il Family Legacy Trust). L'esercizio delle opzioni non ha modificato il numero complessivo di azioni detenute, ma le vendite hanno ridotto la quota del Dynasty Trust del 2,8%. Non sono state aperte o chiuse altre posizioni derivative oltre all'opzione esercitata, che lascia ora 13.695 opzioni in essere per il Trust.
La dimensione della vendita 猫 modesta rispetto alla quota residua di Lewis ed 猫 stata programmata in anticipo, limitando il valore di segnale. Tuttavia, gli investitori spesso interpretano le vendite da parte degli insider, specialmente vicino ai massimi delle 52 settimane (INSM ha superato i 100$), come un possibile indicatore di sentiment.
Insmed Inc. (INSM) 鈥� Transacci贸n insider Formulario 4 fechada 15/07/2025
El presidente y CEO William Lewis, actuando a trav茅s del Katie Procter Dynasty Trust, ejerci贸 6.830 opciones sobre acciones a un precio de ejercicio de 10,85$ y vendi贸 inmediatamente las mismas 6.830 acciones bajo un plan de negociaci贸n Rule 10b5-1 adoptado el 12/09/2024. Las acciones se dispusieron en tres tramos a precios promedio ponderados de 101,71$, 102,66$ y 103,32$, generando aproximadamente 0,7 millones de d贸lares en ingresos brutos.
Tras las transacciones, la propiedad beneficiaria total de Lewis es de 588.335 acciones comunes (303.911 directas; 233.924 a trav茅s del Dynasty Trust; 50.500 a trav茅s del Family Legacy Trust). El ejercicio de las opciones no cambi贸 su conteo total de acciones, pero las ventas redujeron la participaci贸n del Dynasty Trust en un 2,8%. No se abrieron ni cerraron otras posiciones derivadas aparte de la opci贸n ejercida, que ahora deja 13.695 opciones pendientes para el Trust.
El tama帽o de la venta es modesto en relaci贸n con la participaci贸n restante de Lewis y fue programado previamente, limitando su valor como se帽al. Sin embargo, los inversores suelen ver las disposiciones de insiders, especialmente cerca de m谩ximos de 52 semanas (INSM cotiz贸 por encima de 100$), como un posible indicador de sentimiento.
Insmed Inc. (INSM) 鈥� 2025雲� 7鞗� 15鞚检瀽 Form 4 雮措秬鞛� 瓯半灅
須岇灔 瓴� CEO William Lewis電� Katie Procter Dynasty Trust毳� 韱淀暣 頄夓偓臧�瓴� $10.85鞐� 6,830欤� 欤检嫕 鞓奠厴鞚� 頄夓偓頃橁碃, 2024雲� 9鞗� 12鞚� 毂勴儩霅� Rule 10b5-1 瓯半灅 瓿勴殟鞐� 霐半澕 霃欖澕頃� 6,830欤茧ゼ 歃夓嫓 毵る弰頄堨姷雼堧嫟. 欤检嫕鞚� 靹� 彀鞐� 瓯胳硱 臧�欷戫弶攴� 臧�瓴� $101.71, $102.66, $103.32鞐� 觳橂秳霅橃柎 鞎� 70毵� 雼煬鞚� 齑� 靾橃澋鞚� 彀届稖頄堨姷雼堧嫟.
鞚措矆 瓯半灅 頉� Lewis鞚� 齑� 鞁れ 靻岇湢 欤检嫕 靾橂姅 588,335欤� 氤错喌欤�搿� (歆侅爲 303,911欤�; Dynasty Trust毳� 韱淀暣 233,924欤�; Family Legacy Trust毳� 韱淀暣 50,500欤�) 甑劚霅╇媹雼�. 鞓奠厴 頄夓偓電� 鞝勳泊 欤检嫕 靾橃棎電� 氤�霃欖潉 欤检 鞎婌晿鞙茧倶, 毵る弰電� Dynasty Trust鞚� 歆�攵勳潉 2.8% 臧愳唽鞁滌及鞀惦媹雼�. 頄夓偓霅� 鞓奠厴 鞕胳棎 雼るジ 韺岇儩靸來拡 韽靺橃潃 臧滌劋霅橁卑雮� 觳偘霅橃 鞎婌晿鞙茧┌, 順勳灛 Trust鞐愲姅 13,695臧滌潣 鞓奠厴鞚� 雮晞 鞛堨姷雼堧嫟.
毵る弰 攴滊電� Lewis鞚� 雮潃 歆�攵勳棎 牍勴暣 鞝侅潃 韼胳澊氅� 靷爠鞐� 瓿勴殟霅� 瓯半灅搿� 鞁犿樃 臧�旃橁皜 鞝滍暅鞝侅瀰雼堧嫟. 攴鸽熂鞐愲弰 攵堦惮頃橁碃 韴瀽鞛愲摛鞚� 雮措秬鞛� 毵る弰毳�, 韸鬼瀳 52欤� 斓滉碃臧� 攴检矘鞐愳劀(INSM鞚� $100 鞚挫儊 瓯半灅霅�) 膦呾 鞁滌灔 鞁Μ 鞝愱瞼 鞁犿樃搿� 臧勳＜頃╇媹雼�.
Insmed Inc. (INSM) 鈥� Transaction d鈥檌niti茅 Formulaire 4 dat茅e du 15/07/2025
Le Pr茅sident et CEO William Lewis, agissant par l鈥檌nterm茅diaire du Katie Procter Dynasty Trust, a exerc茅 6 830 options d鈥檃chat d鈥檃ctions au prix d鈥檈xercice de 10,85$ et a imm茅diatement vendu les m锚mes 6 830 actions dans le cadre d鈥檜n plan de trading Rule 10b5-1 adopt茅 le 12/09/2024. Les actions ont 茅t茅 c茅d茅es en trois tranches 脿 des prix moyens pond茅r茅s de 101,71$, 102,66$ et 103,32$, g茅n茅rant environ 0,7 million de dollars de produit brut.
脌 la suite de ces op茅rations, la d茅tention b茅n茅ficiaire totale de Lewis s鈥櫭﹍猫ve 脿 588 335 actions ordinaires (303 911 en direct ; 233 924 via le Dynasty Trust ; 50 500 via le Family Legacy Trust). L鈥檈xercice des options n鈥檃 pas modifi茅 son nombre total d鈥檃ctions, mais les ventes ont r茅duit la participation du Dynasty Trust de 2,8 %. Aucune autre position d茅riv茅e n鈥檃 茅t茅 ouverte ou cl么tur茅e en dehors de l鈥檕ption exerc茅e, laissant d茅sormais 13 695 options en circulation pour le Trust.
La taille de la vente est modeste par rapport 脿 la participation restante de Lewis et a 茅t茅 programm茅e 脿 l鈥檃vance, limitant ainsi sa valeur en tant que signal. N茅anmoins, les investisseurs consid猫rent souvent les ventes d鈥檌niti茅s, surtout pr猫s des plus hauts sur 52 semaines (INSM a d茅pass茅 les 100$), comme un indicateur potentiel du sentiment du march茅.
Insmed Inc. (INSM) 鈥� Insider-Transaktion Form 4 vom 15.07.2025
Vorsitzender und CEO William Lewis hat 眉ber den Katie Procter Dynasty Trust 6.830 Aktienoptionen zum Aus眉bungspreis von 10,85$ ausge眉bt und unmittelbar dieselben 6.830 Aktien im Rahmen eines Rule 10b5-1 Handelsplans verkauft, der am 12.09.2024 eingef眉hrt wurde. Die Aktien wurden in drei Tranchen zu gewichteten Durchschnittspreisen von 101,71$, 102,66$ und 103,32$ ver盲u脽ert, was Bruttoerl枚se von etwa 0,7 Millionen Dollar einbrachte.
Nach den Transaktionen besitzt Lewis insgesamt 588.335 Stammaktien (303.911 direkt; 233.924 眉ber den Dynasty Trust; 50.500 眉ber den Family Legacy Trust). Die Optionsaus眉bung 盲nderte seine Gesamtanzahl an Aktien nicht, jedoch verringerten die Verk盲ufe den Anteil des Dynasty Trust um 2,8%. Es wurden keine weiteren Derivatepositionen er枚ffnet oder geschlossen, au脽er der ausge眉bten Option, wodurch nun 13.695 Optionen f眉r den Trust verbleiben.
Die Verkaufsgr枚脽e ist im Verh盲ltnis zu Lewis鈥� verbleibendem Anteil gering und war vorab geplant, was den Signalwert begrenzt. Dennoch sehen Investoren Insiderverk盲ufe, insbesondere nahe 52-Wochen-Hochs (INSM notierte 眉ber 100$), oft als m枚glichen Stimmungsindikator.
FAQ
How many INSM shares did CEO William Lewis sell on 07/15/2025?
At what prices were the INSM shares sold?
Did the CEO buy additional shares of INSM?
What is William Lewis鈥� total INSM share ownership after the transaction?
Was the insider sale pre-planned?
